Toth Financial Advisory’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-20
| Closed | -$491 | – | 845 |
|
|
2023
Q2 | $491 | Hold |
20
| – | – | ﹤0.01% | 741 |
|
|
2023
Q1 | $466 | Sell |
20
-20
| -50% | -$466 | ﹤0.01% | 769 |
|
|
2022
Q4 | $1.01K | Hold |
40
| – | – | ﹤0.01% | 657 |
|
|
2022
Q3 | $1K | Hold |
40
| – | – | ﹤0.01% | 716 |
|
|
2022
Q2 | $1K | Hold |
40
| – | – | ﹤0.01% | 671 |
|
|
2022
Q1 | $1K | Hold |
40
| – | – | ﹤0.01% | 686 |
|
|
2021
Q4 | $2K | Hold |
40
| – | – | ﹤0.01% | 663 |
|
|
2021
Q3 | $2K | Buy |
+40
| New | +$2K | ﹤0.01% | 678 |
|
|
2021
Q1 | – | Sell |
-120
| Closed | -$3K | – | 715 |
|
|
2020
Q4 | $3K | Buy |
120
+70
| +140% | +$1.75K | ﹤0.01% | 507 |
|
|
2020
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 488 |
|
|
2020
Q2 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 472 |
|